These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16197666

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.
    Meijer P, Wouters CW, van den Broek PH, de Rooij M, Scheffer GJ, Smits P, Rongen GA.
    Hypertension; 2010 Oct; 56(4):722-7. PubMed ID: 20679180
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia.
    Ott C, Ritt M, Titze SI, Schäufele T, Schmieder RE.
    J Nephrol; 2009 Oct; 22(5):675-81. PubMed ID: 19810001
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC, Wong AT, Yamashita S, Watts GF.
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [Abstract] [Full Text] [Related]

  • 30. Rosuvastatin improves pulse wave reflection by restoring endothelial function.
    Ott C, Schneider MP, Schlaich MP, Schmieder RE.
    Microvasc Res; 2012 Jul; 84(1):60-4. PubMed ID: 22484031
    [Abstract] [Full Text] [Related]

  • 31. Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels.
    Carter NJ.
    Am J Cardiovasc Drugs; 2010 Jul; 10(6):383-400. PubMed ID: 21090831
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN, Tuomilehto J, Hamann A, Kallend D, Smith K.
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet.
    de las Heras N, Valero-Muñoz M, Ballesteros S, Gómez-Hernández A, Martín-Fernández B, Blanco-Rivero J, Cachofeiro V, Benito M, Balfagón G, Lahera V.
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1107-14. PubMed ID: 23434394
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.